1985
DOI: 10.1111/j.1651-2227.1985.tb14930.x
|View full text |Cite
|
Sign up to set email alerts
|

Problems in the treatment of malabsorption in CF

Abstract: ). Problems in the treatment of malabsorption in CF. Acta Paed Scand Suppl 317.Several factors play a role in the cause of malabsorption in CF. Besides the enzyme deficiency in the secretion of the exocrine pancreas, decreased bile-salt concentration in the gut may also be an important factor in the fat malabsorption. The contribution to the fat absorption by other lipases, such as lingual lipase and gastric lipase, remains to he proved. The therapeutic measures are only partly effective because of the breakdo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1988
1988
2005
2005

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…Despite regular pancreatic enzyme therapy, impaired nutritional status persisted in several patients, as confirmed by biochemical evidence of malnutrition. This impaired status could not have been due to inactivation of the enzymes in the stomach because the pancreatic enzyme supplements are in the form of enteric-coated microspheres that prevent enzyme degradation (10,12,21). The partial response to pancreatic enzyme therapy could, however, have been caused by inactivation of these enzymes in the small intestine as result of a low duodenal pH caused by pancreatic impairment of bicarbonate secretion.…”
Section: Discussionmentioning
confidence: 99%
“…Despite regular pancreatic enzyme therapy, impaired nutritional status persisted in several patients, as confirmed by biochemical evidence of malnutrition. This impaired status could not have been due to inactivation of the enzymes in the stomach because the pancreatic enzyme supplements are in the form of enteric-coated microspheres that prevent enzyme degradation (10,12,21). The partial response to pancreatic enzyme therapy could, however, have been caused by inactivation of these enzymes in the small intestine as result of a low duodenal pH caused by pancreatic impairment of bicarbonate secretion.…”
Section: Discussionmentioning
confidence: 99%
“…Malabsorption in CF can be improved by giving pancreatic extracts with meals [6,97]. An important advance has been enteric coated microspheres resistant to acid which significantly enhances the enzyme activity in the duodenum.…”
Section: Therapy For Malabsorption and Malnutritionmentioning
confidence: 98%
“…However, AA and DHA decrease the secretion of bile-salt dependent lipase, but without directly impairing the biosynthesis of this enzyme. AA alters the transport of the enzyme toward the cytosol, leading to the retention of bile-salt dependent lipase in microsomes [127]. It is likely that much attention must be paid to phospholipases and CET in CF in view of their role in fat absorption.…”
Section: Intraluminal Abnormalitiesmentioning
confidence: 99%